Nutra Pharma Corp (NPHC): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2011-12-31, 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

7.10B
As of 2025-12-31
7.16B
As of 2026-06-30
+0.3%
3-year compound annual growth
2010-12-31: 280.09M2011-12-31: 326.34M2012-12-31: 561.77M2013-12-31: 1.00B2014-12-31: 36.77M2015-12-31: 79.77M2016-12-31: 295.07M2017-12-31: 2.03B2018-12-31: 4.05B2019-12-31: 5.88B2020-12-31: 6.96B2021-12-31: 6.77B2022-12-31: 7.04B2023-12-31: 7.06B2024-12-31: 7.10B2025-12-31: 7.10B7.10B
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-317.10B0.0%2026-05-20, Balance as of period end
2024-12-317.10B+0.5%2026-05-20, Balance as of period end
2023-12-317.06B+0.4%2026-02-17, Balance as of period end
2022-12-317.04B+3.9%2025-11-24, Balance as of period end
2021-12-316.77Bn/c2025-09-03, Balance as of period end
2020-12-316.96B+18.4%2022-04-15, Balance as of period end
2019-12-315.88Bn/c2021-09-08, Balance as of period end
2018-12-314.05Bn/c2021-07-01, Balance as of period end
2017-12-312.03B+588.7%2021-02-05, Balance as of period end
2016-12-31295.07M+269.9%2018-04-17, Balance as of period end
2015-12-3179.77M+117.0%2017-04-17, Balance as of period end
2014-12-3136.77M-96.3%2016-04-14, Balance as of period end
2013-12-311.00B+78.8%2015-04-13, Balance as of period end
2012-12-31561.77M+72.1%2014-03-31, Balance as of period end
2011-12-31326.34Mn/c2013-04-16, Balance as of period end
2010-12-31280.09Mn/a2012-11-15, Balance as of period end